Litcius/Paper detail

SUMOylation and Major Depressive Disorder

Seok-Won Jeoung, Hyun-Sun Park, Zae Young Ryoo, Dong‐Hyung Cho, Hyun‐Shik Lee, Hong‐Yeoul Ryu

2022International Journal of Molecular Sciences13 citationsDOIOpen Access PDF

Abstract

Since the discovery of the small ubiquitin-like modifier (SUMO) protein in 1995, SUMOylation has been considered a crucial post-translational modification in diverse cellular functions. In neurons, SUMOylation has various roles ranging from managing synaptic transmitter release to maintaining mitochondrial integrity and determining neuronal health. It has been discovered that neuronal dysfunction is a key factor in the development of major depressive disorder (MDD). PubMed and Google Scholar databases were searched with keywords such as 'SUMO', 'neuronal plasticity', and 'depression' to obtain relevant scientific literature. Here, we provide an overview of recent studies demonstrating the role of SUMOylation in maintaining neuronal function in participants suffering from MDD.

Topics & Concepts

SUMO proteinNeuroscienceMajor depressive disorderSynaptic plasticityUbiquitinBiologyDepression (economics)Computational biologyBioinformaticsGeneticsCognitionGeneReceptorMacroeconomicsEconomicsUbiquitin and proteasome pathwaysMitochondrial Function and PathologyATP Synthase and ATPases Research
SUMOylation and Major Depressive Disorder | Litcius